Related Experiment Videos

Drug-resistant Streptococcus pneumoniae--Kentucky and Tennessee, 1993

    Insights

    Drug-resistant Streptococcus pneumoniae (DRSP) infections are complicating pneumonia and sepsis treatment. Investigations in Kentucky and Tennessee highlight the growing challenge of managing these resistant bacterial infections.

    Area of Science:

    • Bacteriology
    • Infectious Diseases
    • Public Health

    Background:

    • Streptococcus pneumoniae causes pneumonia, sepsis, meningitis, and acute otitis media globally.
    • Empirical treatment is common due to lack of rapid diagnostics, with penicillin historically as the first choice.
    • Emergence of drug-resistant S. pneumoniae (DRSP) complicates treatment decisions.

    Purpose of the Study:

    • To summarize recent investigations of DRSP in communities.
    • To inform public health officials and clinicians about the DRSP challenge.

    Main Methods:

    • Investigations conducted by the CDC and state public health officials.
    • Focus on DRSP in community settings in Kentucky and Tennessee.

    Main Results:

    • Data on the prevalence and characteristics of DRSP infections.
    • Insights into the impact of DRSP on treatment strategies.

    Conclusions:

    • DRSP poses a significant and growing threat to public health.
    • Management of pneumococcal infections requires updated strategies due to resistance.

    Related Concept Videos